Preparation and application of lactobacillus plantarum ZJUIDS15 metagen for preventing and treating colon cancer

By inactivating and frozen concentrating the fermentation supernatant of Lactobacillus plantarum ZJUIDS15, a postbiotic with antibacterial activity and antioxidant ability was prepared, which solved the stability and storage problems of probiotics in actual applications and achieved colorectal Effective inhibition of cancer cells, especially in abdominal and liver metastasis, showed significant effects.

CN119081914AActive Publication Date: 2024-12-06ZHEJIANG UNIV
View PDF 18 Cites 0 Cited by

Patent Information

Application Number
CN202410854223.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-28
Publication Date
2024-12-06
Estimated Expiration
2044-06-28

AI Technical Summary

Technical Problem

There is a lack of effective alternative anti-cancer drugs in the prior art to prevent and treat colon cancer, and probiotics have problems with strain mutation and storage stability in practical applications, which affects the maintenance of their probiotic functions.

Method used

By inactivating, rotary evaporating, frozen concentration of Lactobacillus plantarum ZJUIDS15 fermentation supernatant, epibiotics with antibacterial activity and antioxidant ability were prepared, and abdominal and liver metastasis of colorectal cancer cells was inhibited by gavage treatment. .

Benefits of technology

The epibiotic prepared by this method can not only stably inhibit the abdominal and liver metastasis of colorectal cancer cells, but also have a long food storage period and safety, and is suitable for the development of functional products of colon cancer.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119081914A_ABST
    Figure CN119081914A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of microorganisms, and particularly relates to preparation and application of a lactobacillus plantarum ZJUIDS15 metagen for preventing and treating colon cancer. The preparation method of the lactobacillus plantarum ZJUIDS15 metagen comprises the following steps: after the lactobacillus plantarum ZJUIDS15 (CGMCC (China General Microbiological Culture Collection Center) NO.26120) fermentation supernatant is inactivated, freezing and concentrating to obtain the lactobacillus plantarum ZJUIDS15 metagen. The lactobacillus plantarum ZJUIDS15 metagen has antibacterial activity and antioxidant capacity, can relieve the abdominal cavity metastasis capacity of colorectal cancer cells after intragastric administration treatment, and can relieve the liver metastasis capacity of the colorectal cancer cells.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of microorganisms, and specifically relates to the preparation and application of a Lactobacillus plantarum ZJUIDS15 postbiotic for preventing and treating colon cancer. Background Art

[0002] Colorectal cancer (CRC) is one of the most common types of cancer worldwide and the second leading cause of cancer-related death worldwide. In recent years, the incidence of colorectal cancer has increased, and more and more attention has been paid to its prevention and treatment. Although there are many treatments for CRC, such as surgery, chemotherapy, and biological therapy, the success rate of cancer treatment is still difficult to predict, the mortality rate is high, and the prognosis of CRC patients is still high. Therefore, there is an urgent need to find alternative anticancer drugs to improve the treatment of colon cancer in the future. Studies have found that the structure of the intestinal flora is closely related to the occurrence and development of CRC.

[0003] As beneficial intestinal microorganisms, probiotics have the functions of regulating intestinal immunity, enhancing intestinal barrier and maintaining the balance of intestinal flora structure, and play an important role in the prevention and adjuvant treatment of CRC. With the deepening of research on probiotics, it is found that not only live bacteria can play a probiotic function, but also inactivated bacterial cells, components released by dissolution after bacterial death, and bacterial metabolites can also promote health.

[0004] Chinese patent CN116396890A discloses the application of Lactobacillus plantarum ZJUIDS15 in preventing and treating colon cancer. The patent provides a Lactobacillus plantarum ZJUIDS15 with the function of preventing and treating colon cancer. Its preservation number is CGMCCNO.26120. The strain has the function of preventing and treating colon cancer, can tolerate the gastrointestinal environment, the culture medium has no antibiotic resistance, inhibits harmful pathogens in the intestine, and has strong antioxidant capacity.

[0005] Chinese patent CN107629987A discloses the application of Lactobacillus plantarum CCFM164 or fermented food, which is characterized by being used to improve intestinal flora, reduce abnormally elevated levels of short-chain fatty acids in the intestine, alleviate colorectal inflammation, and inhibit the occurrence of colorectal cancer.

[0006] However, intestinal microorganisms suitable for preventing and treating colon cancer still need to be further developed. Summary of the invention

[0007] The technical problem to be solved by the present invention is to provide a preparation method and application of a Lactobacillus plantarum ZJUIDS15 postbiotic for preventing and treating colon cancer.

[0008] In order to solve the above technical problems, the present invention provides a method for preparing Lactobacillus plantarum ZJUIDS15 postbiotics for preventing and treating colon cancer: after the fermentation supernatant of Lactobacillus plantarum ZJUIDS15 (CGMCC NO.26120) is inactivated, it is freeze-concentrated (first rotary evaporation concentration, then freeze-concentrated) to obtain Lactobacillus plantarum ZJUIDS15 postbiotics.

[0009] As an improvement on the preparation method of the plant lactobacillus ZJUIDS15 postbiotic of the present invention, the preparation method of the fermentation supernatant of the plant lactobacillus ZJUIDS15 is as follows: one inoculation loop of the plant lactobacillus ZJUIDS15 is inoculated into 100 mL of MRS liquid culture medium, and placed in a 37±0.5°C incubator for culturing for 18±0.5 h; then transferred to a sterilized (high pressure steam sterilization, 121°C, 15 min) 250-300 mL of MRS liquid culture medium with an inoculation amount of 1-2% (volume %); placed in an incubator and cultured at 37±0.5°C for 18±0.5 h; the obtained fermentation broth is centrifuged at 4000-10000 r / min for 15-20 min, and the supernatant is collected.

[0010] As a further improvement of the preparation method of the Lactobacillus plantarum ZJUIDS15 postbiotic of the present invention: the collected supernatant is inactivated in a water bath at 85±2°C for 2±0.1h, and then rotary evaporated to 1 / 3.5 to 1 / 4.5 of the original volume; and the obtained fermentation supernatant concentrate is freeze-concentrated to obtain the Lactobacillus plantarum ZJUIDS15 postbiotic.

[0011] As a further improvement of the preparation method of Lactobacillus plantarum ZJUIDS15 postbiotics of the present invention, the freeze concentration is:

[0012] The fermentation supernatant concentrate was pre-frozen in a -80°C ultra-low temperature refrigerator for no less than 2 h, then quickly taken out and placed in a vacuum freeze dryer for vacuum treatment, with the vacuum degree maintained at 0.1P and the freezing temperature at -55°C. After complete freeze drying (i.e., after freezing to constant weight, freeze drying for about 48 h), the postbiotics of Lactobacillus plantarum ZJUIDS15 were obtained.

[0013] After taking it out, store it in a 4℃ refrigerator.

[0014] The present invention also provides Lactobacillus plantarum ZJUIDS15 postbiotics prepared by any of the above methods.

[0015] As an improvement of the Lactobacillus plantarum ZJUIDS15 postbiotic of the present invention: the Lactobacillus plantarum ZJUIDS15 postbiotic has antibacterial activity and antioxidant capacity, and can alleviate the abdominal metastasis ability of colorectal cancer cells and the liver metastasis ability of colorectal cancer cells after intragastric administration.

[0016] As further improvements of the Lactobacillus plantarum ZJUIDS15 postbiotic of the present invention: preparing live bacterial preparations with the function of preventing and treating colon cancer; preparing products (such as medicines) with the function of preventing and treating colon cancer; preparing bacteriocins with the function of preventing and treating colon cancer.

[0017] That is, the present invention provides: application of Lactobacillus plantarum ZJUIDS15 postbiotics in the preparation of pet milk powder in food, application of Lactobacillus plantarum ZJUIDS15 postbiotics in the preparation of functional milk tablets in food, application of Lactobacillus plantarum ZJUIDS15 postbiotics in the preparation of functional soft candies in food, application of Lactobacillus plantarum ZJUIDS15 postbiotics in the preparation of live bacteria preparations with the function of preventing and treating colon cancer, application of Lactobacillus plantarum ZJUIDS15 postbiotics in the preparation of solid beverages with the function of preventing and treating colon cancer, and application of Lactobacillus plantarum ZJUIDS15 postbiotics in the preparation of bacteriocins with the function of preventing and treating colon cancer.

[0018] The present invention provides a plant lactobacillus postbiotic with the function of preventing and treating colon cancer, which has the function of preventing and treating colon cancer, inhibiting harmful pathogenic bacteria in the intestine and having strong antioxidant capacity. Therefore, the plant lactobacillus ZJUIDS15 postbiotic of the present invention can be widely used in the development of functional products related to colon cancer.

[0019] In view of the lack of research on the role of postbiotics in preventing and treating colorectal cancer, the present invention provides a Lactobacillus plantarum ZJUIDS15 postbiotic for preventing and treating colon cancer and its application. The preventive and therapeutic effect of Lactobacillus plantarum ZJUIDS15 postbiotic on colon cancer is investigated through an animal experimental model.

[0020] The present invention discloses a postbiotic prepared based on the fermentation supernatant of Lactobacillus plantarum ZJUIDS15. The postbiotic has high antibacterial and antioxidant capabilities, is more stable and safer than probiotics, and can provide a basis for developing functional products against colon cancer.

[0021] It should be emphasized that: Patent CN116396890A informs that: Lactobacillus plantarum ZJUIDS15 live bacteria have an in vivo preventive and therapeutic effect on colon cancer, which is specifically manifested in the effect on the peritoneal metastasis of colon cancer cells, and does not reflect the mitigation effect on the liver metastasis ability of colorectal cancer cells. The most common target organ for hematogenous metastasis of colon cancer is the liver, and about 50% of patients will eventually have liver metastasis. At present, radical surgical resection is the only method that can cure colon cancer, but 20% to 50% of patients still have liver metastasis after surgical resection, and the 5-year survival rate is less than 10%. The plant lactobacillus ZJUIDS15 postbiotics of the present invention can not only reduce the peritoneal metastasis of colorectal cancer cells, but also alleviate the liver metastasis ability of colorectal cancer cells. In addition, there are some problems in the actual use of live bacteria, such as strain mutations that lead to changes in their probiotic functions, non-low temperature storage and use process leads to a decrease in the number of live bacteria, etc. Postbiotics are a general term for the probiotic metabolite components of probiotics after processing, including bacteria and metabolites. In contrast, postbiotics have a stable composition, safe dosing parameters and a long food storage period (up to 5 years if used as a raw material or nutritional supplement for food and beverages). Postbiotics can provide food manufacturers with the technical advantages of easy storage, low transportation costs and longer shelf life. Postbiotics have the probiotic function of probiotics, but also save the management of live bacteria, and have a variety of applications, which has broad prospects in the development of new products with health functions. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] The specific implementation modes of the present invention are further described in detail below with reference to the accompanying drawings.

[0023] Figure 1 The postbiotics were prepared from the culture supernatant of Lactobacillus plantarum ZJUIDS15;

[0024] Figure 2 The postbiotics prepared from the culture supernatant of Lactobacillus plantarum ZJUIDS15 inhibited tumor peritoneal metastasis by intragastric administration; Ctrl represents intragastric administration of PBS buffer, and ZJUIDS15 supernatant represents intragastric administration of ZJUIDS15 postbiotic solution;

[0025] Figure 2 middle:

[0026] A shows representative images of bioluminescence results;

[0027] B Statistical analysis of the fluorescence signal results of each group. **p<0.01; Mann-Whitney (B) statistical method was used. The 6 mice in each group were biological replicates within the animal experimental group.

[0028] Figure 3The postbiotics prepared from the culture supernatant of Lactobacillus plantarum ZJUIDS15 inhibited tumor liver metastasis by intragastric administration; Ctrl represents intragastric administration of PBS buffer, and ZJUIDS15 supernatant represents intragastric administration of ZJUIDS15 postbiotic solution;

[0029] Figure 3 middle:

[0030] A shows the tumor metastasis in the liver tissue of each group of mice at the end point of the experiment (scale bar = 1 cm);

[0031] B. Statistical analysis of the weight of liver tissue of mice in each group;

[0032] C shows representative H&E staining images of the liver (scale bar = 200 μm); **p<0.01; statistical method of Mann-Whitney (B) was used. DETAILED DESCRIPTION

[0033] The present invention is further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto:

[0034] Example 1. Preparation of Lactobacillus plantarum ZJUIDS15 postbiotics

[0035] 1.1 Preparation of fermentation supernatant of Lactobacillus plantarum ZJUIDS15

[0036] Inoculate 1 inoculation loop of Lactobacillus plantarum ZJUIDS15 in 100mL MRS liquid medium and place it in a 37°C incubator for 18h. Then transfer it to 300mL MRS liquid medium that has been sterilized (autoclaved, 121°C, 15min) with an inoculation amount of 1% (volume %). Place it in a bacterial incubator and culture it at 37°C for 18h. The resulting fermentation liquid is centrifuged at 4000r / min for 15min to collect the supernatant, and the supernatant after water bath inactivation (85°C, 2h) is rotary evaporated to 1 / 4 of the original volume. The resulting fermentation supernatant concentrate is stored in a 4°C refrigerator for standby use.

[0037] 1.2 Freeze concentration

[0038] The fermentation supernatant concentrate obtained in step 1.1 is vacuum freeze concentrated, specifically: the fermentation supernatant concentrate is pre-frozen in a -80°C ultra-low temperature refrigerator for not less than 2 hours, and then quickly taken out and placed in a vacuum freeze dryer for vacuum treatment, the vacuum degree is maintained at about 0.1P, the freezing temperature is -55°C, and freeze-dried for 48 hours, and completely freeze-dried (i.e., frozen to constant weight), which is the postbiotics of Lactobacillus plantarum ZJUIDS15; after being taken out, it is stored in a 4°C refrigerator.

[0039] Example 2: In vivo preventive and therapeutic effects of Lactobacillus plantarum ZJUIDS15 postbiotics on colon cancer

[0040] 2.1. Sample preparation

[0041] The Lactobacillus plantarum ZJUIDS15 postbiotic prepared in Example 1 was prepared into a ZJUIDS15 postbiotic solution with a concentration of 0.1 g / mL using a PBS buffer solution with a pH of 7.2-7.4 for subsequent experiments.

[0042] 2.2 Effect of oral administration of ZJUIDS15 postbiotic solution (0.1 g / mL) on peritoneal metastasis of colorectal cancer cells

[0043] Mouse CT26-luc (luciferase-labeled) colorectal cancer cells were cultured at 1×10 per BALB / c mouse. 6 The cells were injected into the peritoneal cavity of mice (n=6) at a volume of 100 μl / 300 μl. From the day of modeling, mice in each group were gavaged with 300 μl of ZJUIDS15 postbiotic solution (0.1 g / mL) or PBS buffer (pH 7.2-7.4) every day, and the degree of peritoneal metastasis of mice was detected by in vivo imaging. Figure 2 As shown, the fluorescence signal in the peritoneal cavity of mice treated with ZJUIDS15 postbiotics by oral gavage significantly decreased, suggesting that the ZJUIDS15 postbiotic solution can alleviate the peritoneal metastasis ability of colorectal cancer cells.

[0044] 2.3 Effect of oral administration of ZJUIDS15 postbiotic solution (0.1 g / mL) on liver metastasis of colorectal cancer cells

[0045] Mouse MC38-luc (luciferase-labeled) colorectal cancer cells were cultured at 2×10 per C57 mouse. 6 The cells / 100 μl were injected into the spleen of anesthetized mice to construct a liver metastasis model. After the spleen injection was completed, the spleen was removed, and the wound was sutured and disinfected. On the 7th day of modeling, small animal in vivo imaging was performed to evaluate the modeling situation. Mice with similar tumor growth conditions were randomly divided into 2 groups (n=6), and then each group of mice was gavaged with 300 μl of ZJUIDS15 postbiotic solution (0.1 g / mL) or PBS buffer (pH7.2-7.4) every day. After 16 days of gavage, the mice were killed by cervical dislocation, and the mouse liver tissue was removed, photographed, recorded and weighed. Figure 3As shown in A, in the control group (Ctrl) treated with PBS, the liver metastasis of mice was serious (the liver metastasis of colorectal cancer was marked with a red dotted line). In the group treated with postbiotics prepared with the culture supernatant of Lactobacillus plantarum ZJUIDS15, the liver metastasis ability of colorectal cancer cells was significantly inhibited. The liver weight of mice in the group treated with postbiotics prepared with the culture supernatant of Lactobacillus plantarum ZJUIDS15 was significantly lighter ( Figure 3 B). Figure 3 C is a representative picture of H&E staining of liver tissues of mice in each group, in which tumor metastases appear dark purple. These results suggest that oral administration of ZJUIDS15 postbiotic solution (postbiotics prepared from the culture supernatant of Lactobacillus plantarum ZJUIDS15) can alleviate the liver metastasis ability of colorectal cancer cells.

[0046] It should be noted that patent CN116396890A only states that live Lactobacillus plantarum ZJUIDS15 has an in vivo preventive and therapeutic effect on colon cancer, specifically in terms of its effect on the peritoneal metastasis of colon cancer cells, but does not show an alleviating effect on the liver metastasis of colorectal cancer cells. That is, when live ZJUIDS15 bacteria replace ZJUIDS15 postbiotic solution and the above step 2.3 is followed, the results obtained are no significant difference from the control group (Ctrl).

[0047] Example 3: Antioxidant Capacity Verification of Lactobacillus plantarum ZJUIDS15 Postbiotic Solution

[0048] 1. Preparation of postbiotic solution

[0049] The postbiotics of Lactobacillus plantarum ZJUIDS15 were prepared with reference to Example 1. PBS solvent (pH 7.2-7.4) was used for re-dissolution at a mass ratio of 1:20 to prepare a postbiotic solution, which was used as a sample to be tested for antioxidant capacity verification.

[0050] 2. DPPH free radical scavenging ability determination

[0051] Use deionized water to prepare VC solutions with different concentration gradients (0-30μg / ml). Add 100μL of the sample to be tested (or VC standard solution) and 100μL of 0.2mM DPPH ethanol solution (prepared with anhydrous ethanol, stored at 4℃ away from light, prepared and used immediately) to the ELISA plate, shake well and keep away from light at room temperature for 30 minutes, and measure the absorbance of the solution at 517nm; use 100μL of anhydrous ethanol to replace 100μL of DPPH ethanol solution as the blank group; use 100μL PBS buffer (pH7.2-7.4) (or MRS liquid culture medium) to replace 100μL of the sample to be tested as the control group, and use 100μL PBS buffer (or MRS liquid culture medium) and anhydrous ethanol mixed solution as the blank zero. Repeat 3 times for each sample and calculate the average value.

[0052] DPPH free radical scavenging ability (%) = [1-(As-Ab) / Ac]*100%

[0053] Where: As-absorbance of sample group; Ab-absorbance of blank group; Ac-absorbance of control group.

[0054] Table 1 Antioxidant activity of postbiotics from Lactobacillus plantarum ZJUIDS15

[0055] index Lactobacillus plantarum ZJUIDS15 postbiotic solution DPPH free radical scavenging rate / % 92.4±1.02

[0056] It should be emphasized that: Patent CN116396890A uses live bacteria, and a higher concentration of live bacteria does not mean a better antioxidant effect, and too high a concentration of bacterial solution may also have adverse effects on the human body; the present invention uses postbiotics, and the concentration can be adjusted according to actual needs.

[0057] Example 4: Confirmation of the pathogen inhibition ability of Lactobacillus plantarum ZJUIDS15

[0058] 1. Preparation of Postbiotic Solution

[0059] Lactobacillus plantarum ZJUIDS15 postbiotics were prepared with reference to Example 1. PBS solvent (pH 7.2-7.4) was used for re-dissolution at a mass ratio of 1:5, 1:10, 1:20, 1:30, 1:40, and 1:50 to prepare postbiotic solutions of different concentrations as samples to be tested for antibacterial ability verification.

[0060] 2. Antibacterial Activity Determination

[0061] The antibacterial activity of lactic acid bacteria was determined by the internationally accepted agar diffusion method. The four frozen indicator strains (Escherichia coli, Salmonella, Staphylococcus aureus and Listeria monocytogenes) were activated 2 to 3 times on LB solid medium. The activated single colonies were picked out and placed in LB medium and cultured at 37°C for 18 hours. The bacterial cells were collected by centrifugation and resuspended in saline to a concentration of 10 8 CFU / mL. Add the indicator bacteria suspension at 1% (v / v) to the sterilized LB solid culture medium cooled to about 55°C, mix well and pour into the culture dish (15mL / dish), and remove the sterile Oxford cup placed in advance after condensation. Add the postbiotic solution of Lactobacillus plantarum ZJUIDS15 to the cup hole (200μL / hole), and use PBS (pH7.2-7.4) as a blank control. Culture at 37°C and measure the diameter of the inhibition zone after 24h. Select the strains with obvious inhibition zones around the small holes, measure the diameter of the inhibition zones, and repeat each three times.

[0062] As shown in Table 2, the postbiotic solution of Lactobacillus plantarum ZJUIDS15 has a certain inhibitory effect on Staphylococcus aureus, Escherichia coli, Salmonella typhimurium and Listeria monocytogenes. In addition, the antibacterial ability is different under different reconstitution ratios, and the antibacterial ability decreases with the decrease of postbiotic concentration.

[0063] Table 2 Results of the inhibitory ability of different concentrations of postbiotic solutions on pathogens

[0064]

[0065] Staphylococcus aureus is the most common pathogen in human suppurative infections, some Escherichia coli can cause severe diarrhea and sepsis, and some Salmonella species can also cause food poisoning in humans. Listeria monocytogenes is defined by the World Health Organization as one of the four major foodborne pathogens, and the mortality rate of the diseases caused by it is as high as 20-30%. Lactobacillus postbiotics contain bacteriocins, organic acids, hydrogen peroxide and other antibacterial products that can inhibit the growth of these pathogens alone or together. The postbiotics of Lactobacillus plantarum ZJUIDS15 provided by the present invention have a certain antagonistic effect on these four pathogens and have the potential to develop antibacterial products.

[0066] Example 5: Preparation of pet postbiotic milk powder using Lactobacillus plantarum ZJUIDS15 postbiotics

[0067] 1. Preparation of Lactobacillus plantarum ZJUIDS15 postbiotics

[0068] Prepare Lactobacillus plantarum ZJUIDS15 postbiotics with reference to Example 1.

[0069] 2. Preparation of pet formula powder

[0070] Primary selection of raw materials: milk powder, fish meal, bone meal, grains, vegetable oil, additives: vitamins, trace elements, functional factors, others;

[0071] Automatic batching: put the obtained raw materials into the material bin according to the formula;

[0072] Crushing: crush the weighed materials through a crusher;

[0073] Mixing: Add vegetable oil and trace elements to the crushed materials and put them into the mixer to mix evenly;

[0074] Puffing: The mixed materials are made into granular materials through the puffing machine;

[0075] Drying: The mixed materials are dried in a dryer with the temperature controlled at 65-70 degrees;

[0076] Grading screening: The logistics is passed through the grading screen and the particles are controlled at 2.5-5 mm.

[0077] 3. Preparation of pet postbiotic formula powder

[0078] The postbiotics prepared in step 1 and the pet feed prepared in step 2 are evenly mixed in a ratio of 10:100. After the product is filled, it is stored in the warehouse for sale.

[0079] Example 6: Preparation of postbiotic nutritional milk tablets using Lactobacillus plantarum ZJUIDS15 postbiotics

[0080] 1. Preparation of Lactobacillus plantarum ZJUIDS15 postbiotics

[0081] Prepare Lactobacillus plantarum ZJUIDS15 postbiotics with reference to Example 1.

[0082] 2. Processing process of Houshengyuan milk tablets

[0083] Batching→mixing→granulation→drying→size particles→tablet pressing.

[0084] 3. Operation points

[0085] (1) Ingredients: 100 g full-fat sweet milk powder, 20 g postbiotic powder, 15 g microcrystalline cellulose (MCC), 10 g xylitol, and the amount of magnesium stearate is 0.5% of the total mass of dry particles.

[0086] (2) Mixing: Weigh the raw materials and auxiliary materials according to the dosage of the milk tablet formula, put them into a blender, and mix them by equal amount addition method. The mixing and stirring time of the ingredients is about 10 minutes.

[0087] (3) Granulation: After all components in the milk tablets are fully mixed, add an appropriate amount of 70% alcohol as a wetting agent, and stir and mix while adding to prepare a soft material. When the soft material reaches the standard of "forming a ball when held in the hand and falling apart when lightly pressed", stop adding the wetting agent and prepare wet granules using a granulator equipped with a 20-mesh nylon screen.

[0088] (4) Drying: The wet granules were dried under vacuum at 50°C and turned over every 0.5 h during the drying process to ensure that the granules were uniformly dried.

[0089] (5) Granulation: When the moisture content of the wet granules is less than 3%, the drying is stopped and the dry granules are forced through a 16-mesh screen by a granulator for granulation.

[0090] (6) Tableting: Weigh the mass of the dry granules, add an appropriate amount of magnesium stearate as a lubricant, mix well, adjust the pressure, and use a rotary tablet press equipped with a suitable tableting mold to tablet, thereby obtaining the Houshengyuan milk tablets.

[0091] Example 7: Preparation of postbiotic nutritional soft candy using Lactobacillus plantarum ZJUIDS15 postbiotics

[0092] 1. Preparation of Lactobacillus plantarum ZJUIDS15 postbiotic solution

[0093] The postbiotics of Lactobacillus plantarum ZJUIDS15 were prepared with reference to Example 1, and the postbiotic solution was prepared at a mass ratio of 40%.

[0094] 2. Processing process of postbiotic soft candy

[0095]

[0096] 3. Operation points

[0097] (1) Boiling sugar solution: Add isomalt and maltitol (addition amount 80%) into the sugar boiling pot, stir and boil until the sugar solution is not easy to fall apart when picked up (temperature is about 110°C).

[0098] (2) Preparation of colloid: Soak pectin (addition amount 9.0%) with 1.5 times the amount of water, place in a constant temperature water bath at 85°C and stir to dissolve it, and set aside.

[0099] (3) Mixing and boiling: After the sugar solution is cooled to 70°C and mixed evenly with the gelatin solution, the postbiotic solution (added amount 10%), citric acid (added amount 0.15%), etc. are finally added and mixed, and the mixture is kept warm and allowed to stand.

[0100] (4) Casting: Before casting, apply an appropriate amount of release oil on the mold to facilitate casting and demolding.

[0101] (5) Drying and dehydration: After demolding, place the sample in a drying room and dry it for 36 hours. Note that pectin is easily affected by temperature and melts, so the temperature must be strictly controlled.

[0102] Example 8: Preparation of postbiotic powder with the efficacy of preventing and treating colon cancer using Lactobacillus plantarum ZJUIDS15 postbiotic

[0103] 1. Preparation of Lactobacillus plantarum ZJUIDS15 postbiotics

[0104] Prepare Lactobacillus plantarum ZJUIDS15 postbiotics with reference to Example 1.

[0105] 2. Preparation of Lactobacillus plantarum ZJUIDS15 slurry

[0106] Pick a single colony of plant lactobacillus ZJUIDS15 and inoculate it in 50mL MRS liquid medium, and place it in a 37°C incubator to cultivate for 18h. Activate it again in 250mL MRS liquid medium at 5% inoculum, and place it in a 37°C incubator to cultivate for 24h. Finally, the activated plant lactobacillus ZJUIDS15 is cultured in a 10L fermenter at a high density anaerobic culture with a 5% inoculum, and cultivated for 18h at 37°C and pH 6.8. Afterwards, centrifuge for 15min at 8000r / min and 4°C, discard the supernatant, collect the bacterial precipitation, and rinse the bacterial body twice with sterile phosphate buffer (pH 7.0). You can get the plant lactobacillus ZJUIDS15 bacterial mud.

[0107] 3. Preparation of Protective Agent

[0108] The freeze-dried protective agent contains 15% skim milk powder, 5% trehalose, 3% sodium glutamate, 1% glycerol, and 0.5% cysteine ​​hydrochloride. Water is used as the solvent. Sterilize at 110°C for use.

[0109] 4. Preparation of probiotic powder containing Lactobacillus plantarum ZJUIDS15 postbiotics with the efficacy of preventing and treating colon cancer

[0110] The prepared Lactobacillus plantarum ZJUIDS15 postbiotic powder and the Lactobacillus plantarum ZJUIDS15 bacterial precipitate were fully mixed in a ratio of 1:1:4. Pre-freeze at -40°C for 5 hours to freeze evenly on the inner wall of the container, and then vacuum freeze-dry. After drying for 18 to 20 hours, a probiotic powder containing Lactobacillus plantarum ZJUIDS15 postbiotics with the effect of preventing and treating colon cancer can be obtained. After rehydration with physiological saline, it was washed twice, and the number of live bacteria in the Lactobacillus plantarum ZJUIDS15 powder was measured to be 1.0×10 11 ~1×10 12 CFU / g.

[0111] Example 9: Postbiotic solid beverage using Lactobacillus plantarum ZJUIDS15 with the function of preventing and treating colon cancer

[0112] 1. Preparation of Lactobacillus plantarum ZJUIDS15 postbiotics: Prepare Lactobacillus plantarum ZJUIDS15 postbiotics with reference to Example 1.

[0113] 2. The formula of solid beverage is as follows: edible corn starch, white sugar (10%), oligofructose (6%), oligosaccharide

[0114] Maltose (9%), citric acid, flavoring, postbiotic powder (2-5%)

[0115] 3. Mixed packaging: Add according to the formula and mix evenly, pack according to 10 / 20g per small package, and pack 10-20 small packages into a large package.

[0116] Example 10: Postbiotic bacteriocin using Lactobacillus plantarum ZJUIDS15 with the function of preventing and treating colon cancer

[0117] 1. Preparation of a postbiotic solution of Lactobacillus plantarum ZJUIDS15 with the function of preventing and treating colon cancer

[0118] The Lactobacillus plantarum ZJUIDS15 postbiotics were prepared with reference to Example 1, and the solution was re-dissolved in PBS solvent (pH 7.2-7.4) at a mass ratio of 1:20. The pH value was adjusted to 6.0 with 2M NaOH solution, and the resulting postbiotic solution (pH 6.0) was stored in a 4°C refrigerator for later use.

[0119] 2. Ammonium sulfate precipitation

[0120] Slowly add the pre-weighed (NH4)2SO4 solid powder to the postbiotic solution (pH 6.0) with stirring until the final ammonium sulfate saturation is 60%. Stir with a magnetic stirrer during the addition process. Then place the sample at 4°C overnight to achieve sufficient precipitation. Centrifuge at 4°C for 20 minutes at a speed of 10000r / min to separate the precipitate. Then use a sufficient amount of 50mmol / L pH 6.0 phosphate buffer (PBS) to dissolve the precipitate; obtain the crude bacteriocin solution obtained after ammonium sulfate treatment; finally store it in a 4°C refrigerator for use.

[0121] 3. G-25 dextran gel chromatography

[0122] The crude bacteriocin solution obtained after the treatment with ammonium sulfate was filtered through a 0.22 μm filter membrane and then slowly added to the G-25 dextran gel chromatography, eluted with ultrapure water at a flow rate of 1.0 mL / min, and the collected protein components were detected at 280 nm, and BaCl2 was used to detect whether the collected protein components had salt residues. The protein components that did not precipitate with BaCl2 were the purified bacteriocin solution, which was collected. The antibacterial activity was determined by the agar diffusion Oxford cup method using 4 pathogenic bacteria (Escherichia coli, Salmonella, Staphylococcus aureus and Listeria monocytogenes) as indicator bacteria.

[0123] 4. Freeze Concentration

[0124] The bacteriocin solution collected after the dextran gel chromatography is concentrated by vacuum freezing, specifically: the bacteriocin solution is pre-frozen in a -80°C ultra-low temperature refrigerator for not less than 2 hours, and then quickly taken out and placed in a vacuum freeze dryer for vacuum treatment, and the vacuum degree is maintained at about 0.1P. After concentrating to 1 / 5 of the original volume, the bacteriocin is taken out under reduced pressure and placed in a 4°C refrigerator, and is slowly dissolved in its frozen state; the bacteriocin prepared by the postbiotics of Lactobacillus plantarum ZJUIDS15 can be obtained.

[0125] Compared with the bacteriocin process of CN116396890A, the bacteriocin preparation process of the present invention simplifies the preparation process, omits the process of bacterial culture and the like, and can be directly prepared from the postbiotic raw materials and then re-dissolved.

[0126] Finally, it should be noted that the above examples are only some specific embodiments of the present invention. Obviously, the present invention is not limited to the above embodiments, and there are many variations. All variations that can be directly derived or associated with the content disclosed by a person skilled in the art should be considered as the protection scope of the present invention.

Claims

1. Preparation method of Lactobacillus plantarum ZJUIDS15 postbiotics for preventing and treating colon cancer, Features: The fermentation supernatant of Lactobacillus plantarum ZJUIDS15 was inactivated and then frozen and concentrated to obtain Lactobacillus plantarum ZJUIDS15 postbiotics.

2. The preparation method of the postbiotic Lactobacillus plantarum ZJUIDS15 for preventing and treating colon cancer according to claim 1, Features: The preparation method of the fermentation supernatant of Lactobacillus plantarum ZJUIDS15 is as follows: one inoculation loop of Lactobacillus plantarum ZJUIDS15 is inoculated into 100 mL of MRS liquid culture medium, and the culture medium is placed in a 37±0.5° C. incubator for 18±0.5 h; then the inoculation amount is transferred to a sterilized 250-300 mL of MRS liquid culture medium at 1-2%; the culture medium is placed in a 37±0.5° C. incubator for 18±0.5 h; the obtained fermentation liquid is centrifuged at 4000-10000 r / min for 15-20 min, and the supernatant is collected.

3. The preparation method of the postbiotic of Lactobacillus plantarum ZJUIDS15 for preventing and treating colon cancer according to claim 2, Features: The collected supernatant was inactivated in a water bath at 85±2°C for 2±0.1h, and then rotary evaporated to 1 / 3.5-1 / 4.5 of the original volume; the obtained fermentation supernatant concentrate was then freeze-concentrated to obtain Lactobacillus plantarum ZJUIDS15 postbiotics.

4. The preparation method of the postbiotic of Lactobacillus plantarum ZJUIDS15 for preventing and treating colon cancer according to claim 3, Features The freeze concentration is: The fermentation supernatant concentrate was pre-frozen in a -80°C ultra-low temperature refrigerator for no less than 2 hours, and then quickly taken out and placed in a vacuum freeze dryer for vacuum treatment. The vacuum degree was maintained at 0.1P and the freezing temperature was -55°C. After complete freeze drying, the postbiotics of Lactobacillus plantarum ZJUIDS15 were obtained.

5. The postbiotic of Lactobacillus plantarum ZJUIDS15 prepared by any method of claims 1 to 4.

6. The Lactobacillus plantarum ZJUIDS15 postbiotic according to claim 5, Features: Lactobacillus plantarum ZJUIDS15 postbiotics have antibacterial activity, antioxidant capacity, and the ability to alleviate the abdominal metastasis of colorectal cancer cells and the ability to alleviate the liver metastasis of colorectal cancer cells.

7. Application of the plant lactobacillus ZJUIDS15 postbiotic as claimed in claim 5 or 6, Features: Preparation of live bacterial preparations with the function of preventing and treating colon cancer; Preparation of products with the function of preventing and treating colon cancer; Preparation of bacteriocin with the function of preventing and treating colon cancer.

Citation Information

Patent Citations

  • Lactobacillus paracasei for preventing and treating colon cancer, and application thereof

    CN114085792A

  • Lactobacillus plantarum AY01 and application thereof

    CN116144530A

  • Lactobacillus plantarum ZJUIDS15 for preventing and treating colon cancer and application thereof

    CN116396890A

  • Lactobacillus plantarum with colon cancer cell growth inhibition effect and application thereof

    CN116463264A

  • Lactobacillus fermentum with colon cancer cell growth inhibition effect and application thereof

    CN116836879A